VAN DER SCHAAF, PAUL ADRIAAN,保罗 安卓安 凡 德 史卡夫,保羅 安卓安 凡 德 史卡夫,BLATTER, FRITZ,弗瑞兹 布莱瑞特,弗瑞茲 布萊瑞特,SZELAGIEWICZ, MARTIN,马汀 杰拉格威克兹,馬汀 傑拉格威克茲,凯威 史固宁,凱威 史固寧
申请号：
TW100127719
公开号：
TW201213311A
申请日:
2004.02.10
申请国别(地区):
TW
年份:
2012
代理人:
摘要：
The present invention is directed to new crystalline forms of Pitavastatin hemicalcium salt, referred to hereinafter as polymorphic Forms A, B, C, D, E and F, as well as the amorphous form. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms and the amorphous form and pharmaceutical compositions comprising these crystalline forms or the amorphous form.本發明係針對匹伐他汀半鈣鹽(Pitavastatin hemicalcium calcium)的新晶形,其在以下稱為多晶形A、B、C、D、E和F,以及非晶形。再者,本發明係針對這些晶形和非晶形的製備方法,及含這些晶形或非晶形的藥學組成物。
